Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy

First posted May 25, 2017

Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification

4 participants · First posted Apr 10, 2017

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

1 participants · First posted Feb 23, 2017

von Willebrand Factor/Factor VIII

Factor VIII:c

Preimplantation factor

C₆₇H₁₁₅N₂₁O₂₃S

Raban Victor Jeger

Switzerland

CENTRE HOSPITALIER VICTOR DUPOUY

France

VICTOR WELDING SUPPLY COMPANY

United States

Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy

Victor Ambros and Gary Ruvkun Awarded Nobel Prize for microRNA Discovery

VICTOR Trial Shows Neutral Primary Outcome for Vericiguat in Stable Heart Failure Patients